PLRX Q2 2023 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PLRXPliant Therapeutics, Inc.

$85M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$248,000-95.0% YoY

Gross Profit

-$856,000-345.2% margin

Operating Income

-$47M-19083.9% margin

Net Income

-$41M-16609.7% margin

EPS (Diluted)

$-0.70

QoQ Revenue Growth

-81.4%

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$25M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$575M

Total Liabilities

$42M

Stockholders' Equity

$533M

Cash & Equivalents

$55M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$248,000	$5M	-95.0%
Gross Profit	-$856,000	$5M	-117.2%
Operating Income	-$47M	-$30M	-59.7%
Net Income	-$41M	-$30M	-39.4%